Long COVID as an independent predictor of myasthenia gravis exacerbation: A prospective cohort study integrating
Yan Li1, Yimin Tao2, Zhilan Zhao3
1Faculty of Chinese Medicine & State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, China; Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Macau, China; The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, China.
Objectives:
This study evaluates the impact of long coronavirus disease (Long COVID) on disease exacerbation in patients with myasthenia gravis (MG) and leverages machine learning (ML) approaches to identify high-risk patients.
Methods:
Patients with MG and COVID-19 co-infection were recruited from December 5, 2022, to January 20, 2023, at the Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine (ChiCTR2400087937). Participants underwent structured interviews at 1, 6, and 12 months post-COVID-19 to assess the incident Long COVID and MG exacerbation. The primary outcomes included the incidence and severity of MG exacerbation; the secondary outcome was 12-month mortality. Cox proportional hazards regression was employed to explore the correlation between Long COVID and MG exacerbation. ML algorithms were implemented for predictive modeling.
Results:
Among 180 patients, 62 (34.4 %) experienced MG exacerbation within 12 months, and severe exacerbations (MG-ADL ≥6 points) accounted for 43.5 % of cases. Among those with initial MG exacerbations, 14.4 % continued to exhibit persistent symptoms without full recovery by the 12-month follow-up. Six fatalities (3.3 %) were recorded. Long COVID served as the strongest predictor of exacerbation (aHR = 2.55, 95 % CI 1.47-4.42, P = 0.001), followed by acetylcholinesterase (AChE) inhibitor use (aHR = 2.38) and severe COVID-19 classification (aHR = 2.30). The Random Forest model (RF) outperformed other algorithms, achieving an AUC of 0.83, with Long COVID as the top predictive feature.
Conclusions:
Long COVID is associated with MG exacerbation over time. RF model shows potential as a scalable tool for MG exacerbation risk stratification.
Related Concept Videos
01:15Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:20Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:26Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes: